Genitourinary malignancies in the UAE

The incidence of GU malignancies, specifically prostate cancer, in the United Arab Emirates (UAE) is expected to rise in the coming decade due to changing population demographics and an aging population. There is an urgent need to establish population-based screening for prostate cancer, improve public awareness of the symptoms of GU malignancies, and control tobacco use. In general, patients have access to sub-specialist multidisciplinary care, the latest diagnostic and treatment modalities, and recently approved systemic therapies. Our recommendations include strengthening the UAE cancer registry to include treatment outcome data, adherence to recognized national and international guidelines, multidisciplinary sub-specialist care for all patients regardless of location or financial resources, and promotion of context-specific research collaboration.